School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

David Schuster MD, FACR

  • Department of Radiology and Imaging Sciences
    Professor
  • (404) 712-4859
Head shot of David Schuster

Overview

Dr. Schuster is Director of the Division of Nuclear Medicine and Molecular Imaging and is a Georgia Research Alliance Distinguished Scientist. He serves in an NIH study section and reviews for medical journals. Dr. Schuster is widely published and has lectured nationally and internationally. Dr. Schuster is the recipient of the Society of Nuclear Medicine Tetalman Award and is also known for his co-authorship of the book A Clinicians Guide to Nuclear Medicine.

Academic Appointment

  • Professor, Radiology, Emory University School of Medicine

Education

Degrees

  • MD from Albany Medical College
  • BS from Rensselaer Polytechnic Institute

Research

Focus

  • My research focuses on molecular and nuclear imaging, with a special emphasis on improving cancer diagnosis and staging using novel radiotracers and positron emission tomography cancer imaging, including the use of image fusion techniques. A specific concentration of my research is amino acid transport imaging for oncologic applications. I also maintain active research interests in the field of medical informatics and integrative medicine.

Publications

  • Beyond the AJR: Is Molecular Imaging With 11C-Metomidate PET/CT a Suitable Noninvasive Alternative to Adrenal Vein Sampling for Detecting Surgically Curable Primary Aldosteronism?
    AJR Am J Roentgenol
    04/16/2025 Authors: Lawal IO; Schuster DM
  • Diuresis During 18F-Flotufolastat (rhPSMA-7.3) PET/CT Improves Recurrence Detection After Prostatectomy: A Prospective Phase II Trial.
    J Nucl Med Volume: 66 Page(s): 230 - 237
    02/03/2025 Authors: Lawal IO; Mushtaq A; Jani AB; Rupji M; Dhere VR; Patel SA; Bilen MA; Patel PR; Sebastian NT; Switchenko JM
  • PPV of Bone Uptake of 18F-Flotufolastat: Evaluation Using SPOTLIGHT Study Data.
    AJR Am J Roentgenol Volume: 223 Page(s): e2431698
    11/01/2024 Authors: Schuster DM; Jani AB; Marcus CV; Chau A; Davis P
  • Prospective investigation of amino acid transport and PSMA-targeted positron emission tomography for metastatic lobular breast carcinoma.
    Eur J Nucl Med Mol Imaging Volume: 51 Page(s): 4073 - 4082
    11/01/2024 Authors: Mushtaq A; Lawal IO; Muzahir S; Friend SC; Bhave M; Meisel JL; Torres MA; Styblo TM; Graham CL; Kalinsky K
  • [89Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial.
    Lancet Oncol Volume: 25 Page(s): 1277 - 1287
    10/01/2024 Authors: Shuch B; Pantuck AJ; Bernhard J-C; Morris MA; Master V; Scott AM; van Praet C; Bailly C; nal B; Aksoy T
  • 18F-Flotufolastat Positron Emission Tomography in African American Patients With Suspected Prostate Cancer Recurrence: Findings From the Phase 3 SPOTLIGHT Study.
    Adv Radiat Oncol Volume: 9 Page(s): 101571
    09/01/2024 Authors: Rais-Bahrami S; Fleming M; Gartrell B; Lavely WC; Chau A; Davis P; Schuster DM
  • Resin-Based 90 Y Tumor Dose as a Predictor of Duration of Response and Survival in Patients With Surgically Unresectable Hepatocellular Carcinoma : A Prospective Single-Arm Study.
    Clin Nucl Med Volume: 49 Page(s): 799 - 805
    09/01/2024 Authors: Kokabi N; Webster LA; Dabbous H; Shah A; Brandon D; Galt J; Xing M; Villalobos A; Davarpanahfakhr A; Kappadath SC
  • Impact of Clinical Factors on 18F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study.
    Adv Radiat Oncol Volume: 9 Page(s): 101532
    08/01/2024 Authors: Lowentritt BH; Jani AB; Helfand BT; Uchio EM; Morris MA; Michalski JM; Chau A; Davis P; Chapin BF; Schuster DM
  • Interreader and Intrareader Reproducibility of 18F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter Studies.
    J Nucl Med Volume: 65 Page(s): 1239 - 1243
    08/01/2024 Authors: Kuo PH; Esposito G; Ulaner GA; Yoo D; Zukotynski K; Ravizzini GC; Penny R; Miller MP; Chau A; Davis P
  • True-Positive 18F-Flotufolastat Lesions in Patients with Prostate Cancer Recurrence with Baseline-Negative Conventional Imaging: Results from the Prospective, Phase 3, Multicenter SPOTLIGHT Study.
    J Nucl Med Volume: 65 Page(s): 1080 - 1086
    07/01/2024 Authors: Fleming MT; Hermsen R; Purysko AS; Chau A; Davis P; Chapin BF; Schuster DM
  • Biochemical Relapse-Free Survival in Postprostatectomy Patients Receiving 18F-Fluciclovine-Guided Prostate Bed-Only Radiation: Post Hoc Analysis of a Prospective Randomized Trial.
    Volume: 14 Page(s): e492 - e499
    01/01/2024 Authors: Dhere VR; Schuster DM; Goyal S; Schreibmann E; Hershatter BW; Patel SA; Shelton JW; Hanasoge S; Patel PR; Sebastian NT
  • Prostate Cancer Skeletal Metastasis: A Spontaneous Evolution from Osteolytic to Osteoblastic Morphology without Treatment.
    World J Nucl Med Volume: 22 Page(s): 316 - 320
    12/01/2023 Authors: Lawal IO; Bilen MA; Halkar RK; Jani AB; Schuster DM
  • Integrated Genomic Analysis of Primary Prostate Tumor Foci and Corresponding Lymph Node Metastases Identifies Mutations and Pathways Associated with Metastasis.
    Cancers (Basel) Volume: 15
    11/30/2023 Authors: Moreno CS; Winham CL; Alemozaffar M; Klein ER; Lawal IO; Abiodun-Ojo OA; Patil D; Barwick BG; Huang Y; Schuster DM
  • Evaluation of Treatment Response in Patients with Breast Cancer.
    PET Clin Volume: 18 Page(s): 517 - 530
    10/01/2023 Authors: Muzahir S; Ulaner GA; Schuster DM
  • Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE).
    Eur Urol Volume: 84 Page(s): 361 - 370
    10/01/2023 Authors: Surasi DS; Eiber M; Maurer T; Preston MA; Helfand BT; Josephson D; Tewari AK; Somford DM; Rais-Bahrami S; Koontz BF
  • Stronger Together-Collaboration Will Only Enhance Patient Care.
    J Nucl Med Volume: 64 Page(s): 1356 - 1358
    09/01/2023 Authors: Grady EE; Mankoff DA; Schuster DM
  • Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). Reply.
    J Urol Volume: 210 Page(s): 411 - 412
    09/01/2023 Authors: Jani AB; Ravizzini GC; Gartrell BA; Siegel BA; Twardowski P; Saltzstein D; Fleming MT; Chau A; Davis P; Chapin BF
  • Aberrant Vascular Anatomy Associated With Artifactual Focal Avidity in the Liver on PSMA PET.
    Clin Nucl Med Volume: 48 Page(s): e455 - e457
    09/01/2023 Authors: Lawal IO; Pectasides M; Parihar AS; Shah HU; Halkar RK; Jani AB; Schuster DM
  • Reply by Authors.
    J Urol Volume: 210 Page(s): 310 - 311
    08/01/2023 Authors: Jani AB; Ravizzini GC; Gartrell BA; Siegel BA; Twardowski P; Saltzstein D; Fleming MT; Chau A; Davis P; Chapin BF
  • Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT).
    J Urol Volume: 210 Page(s): 299 - 311
    08/01/2023 Authors: Jani AB; Ravizzini GC; Gartrell BA; Siegel BA; Twardowski P; Saltzstein D; Fleming MT; Chau A; Davis P; Chapin BF
  • ACR Appropriateness Criteria Post-Treatment Follow-up of Prostate Cancer: 2022 Update.
    J Am Coll Radiol Volume: 20 Page(s): S164 - S186
    05/01/2023 Authors: Expert Panel on Urologic Imaging; Turkbey B; Oto A; Allen BC; Akin O; Alexander LF; Ari M; Froemming AT; Fulgham PF; Gettle LM
  • Voxel-based dosimetry predicting treatment response and related toxicity in HCC patients treated with resin-based Y90 radioembolization: a prospective, single-arm study.
    Eur J Nucl Med Mol Imaging Volume: 50 Page(s): 1743 - 1752
    05/01/2023 Authors: Kokabi N; Arndt-Webster L; Chen B; Brandon D; Sethi I; Davarpanahfakhr A; Galt J; Elsayed M; Bercu Z; Cristescu M
  • Differences in Failure-Free Survival After Salvage Radiotherapy Guided by Conventional Imaging Versus 18F-Fluciclovine PET/CT in Postprostatectomy Patients: A Post Hoc Substratification Analysis of the EMPIRE-1 Trial.
    J Nucl Med Volume: 64 Page(s): 586 - 591
    04/01/2023 Authors: Lawal IO; Jani AB; Adediran OA; Goyal S; Abiodun-Ojo OA; Dhere VR; Marcus CV; Joshi SS; Master VA; Patel PR
  • A Discordant Pattern of Uptake on 68 Ga-PSMA PET/CT Versus 18 F-Fluciclovine PET/CT in Radiation-Induced Hepatitis : Implications for Early Postradiotherapy Imaging-Based Response Assessment.
    Clin Nucl Med Volume: 48 Page(s): e202 - e203
    04/01/2023 Authors: Adediran OA; Lawal IO; Muzahir S; Bhave MA; Friend S; Fielder B; Meisel J; Torres MA; Styblo TM; Graham C
  • Treatment Response to Lycopene in Recurrent Prostate Cancer Confirmed on 18 F-Fluciclovine PET/CT.
    Clin Nucl Med Volume: 48 Page(s): 361 - 363
    04/01/2023 Authors: Wu C; Marcus C; Baum Y; Kucuk O; Schuster DM
  • Impact of 18 F-Fluciclovine PET/CT Findings on Failure-Free Survival in Biochemical Recurrence of Prostate Cancer Following Salvage Radiation Therapy.
    Clin Nucl Med Volume: 48 Page(s): e153 - e159
    04/01/2023 Authors: Lawal IO; Marcus C; Schuster DM; Goyal S; Adediran OA; Dhere VR; Joshi SS; Abiodun-Ojo OA; Master VA; Patel PR
  • Lesion segmentation on 18F-fluciclovine PET/CT images using deep learning.
    Front Oncol Volume: 13 Page(s): 1274803
    01/01/2023 Authors: Wang T; Lei Y; Schreibmann E; Roper J; Liu T; Schuster DM; Jani AB; Yang X
  • Correlation of Non-tumoral Liver Dose with Treatment-Related Adverse Events in Patients with Hepatocellular Carcinoma Treated with Glass-Based Yttrium-90 Radioembolization.
    Cardiovasc Intervent Radiol Volume: 46 Page(s): 60 - 68
    01/01/2023 Authors: Webster LA; Villalobos A; Cheng B; Xing M; Majdalany BS; Bercu ZL; Cristescu MM; Brandon D; Schuster D; Baum Y
  • A Tale of 3 Tracers: Contrasting Uptake Patterns of 18F-Fluciclovine, 68Ga-PSMA, and 18F-FDG in the Uterus and Adnexa.
    Clin Nucl Med Volume: 48 Page(s): e26 - e27
    01/01/2023 Authors: Lawal IO; Adediran OA; Muzahir S; Friend S; Bhave MA; Meisel J; Torres MA; Styblo TM; Graham C; Holbrook A
  • Prognostic Evaluation of Metastatic Castration Resistant Prostate Cancer and Neuroendocrine Prostate Cancer with [68Ga]Ga DOTATATE PET-CT.
    Cancers (Basel) Volume: 14
    12/08/2022 Authors: Bilen MA; Akintayo A; Liu Y; Abiodun-Ojo O; Kucuk O; Carthon BC; Schuster DM; Parent EE
  • Accuracy and Safety of Scout Dose Resin Yttrium-90 Microspheres for Radioembolization Therapy Treatment Planning: A Prospective Single-Arm Clinical Trial.
    J Vasc Interv Radiol Volume: 33 Page(s): 1578 - 1587.e5
    12/01/2022 Authors: Kokabi N; Webster LA; Elsayed M; Switchenko JM; Chen B; Brandon D; Galt J; Sethi I; Cristescu M; Kappadath SC
  • Prostate Cancer Imaging with 18F-Fluciclovine.
    PET Clin Volume: 17 Page(s): 607 - 620
    10/01/2022 Authors: Savir-Baruch B; Schuster DM
  • 18F-Fluciclovine PET/CT: A Potential Imaging Biomarker for the Evaluation of Multiple Myeloma.
    Clin Nucl Med Volume: 47 Page(s): e613 - e615
    09/01/2022 Authors: Marcus C; Schuster DM; Tajmir SH
  • MRI-based prostate and dominant lesion segmentation using cascaded scoring convolutional neural network.
    Med Phys Volume: 49 Page(s): 5216 - 5224
    08/01/2022 Authors: Eidex ZA; Wang T; Lei Y; Axente M; Akin-Akintayo OO; Ojo OAA; Akintayo AA; Roper J; Bradley JD; Liu T
  • Randomized Trial of Conventional Versus Conventional Plus Fluciclovine (18F) Positron Emission Tomography/Computed Tomography-Guided Postprostatectomy Radiation Therapy for Prostate Cancer: Volumetric and Patient-Reported Analyses of Toxic Effects.
    Int J Radiat Oncol Biol Phys Volume: 113 Page(s): 1003 - 1014
    08/01/2022 Authors: Dhere VR; Schuster DM; Goyal S; Schreibmann E; Hershatter BW; Rossi PJ; Shelton JW; Patel PR; Jani AB
  • Deep-Learning-Based Lesion Segmentation On 18F-Fluciclovine PET/CT
    Volume: 49 Page(s): E795 - E795
    06/01/2022 Authors: Wang T; Lei Y; Schreibmann E; Roper J; Schuster D; Liu T; Jani A; Yang X
  • ACR Appropriateness Criteria Staging and Surveillance of Testicular Cancer: 2021 Update.
    J Am Coll Radiol Volume: 19 Page(s): S194 - S207
    05/01/2022 Authors: Expert Panel on Urological Imaging; Schieda N; Oto A; Allen BC; Akin O; Barker SJ; Fulgham PF; Gettle LM; Maranchie JK; Patel BN
  • Predictors and Real-World Use of Prostate-Specific Radioligand Therapy: PSMAand Beyond.
    Am Soc Clin Oncol Educ Book Volume: 42 Page(s): 1 - 17
    04/01/2022 Authors: Gafita A; Marcus C; Kostos L; Schuster DM; Calais J; Hofman MS
  • 82Rubidium chloride positron emission tomography discrimination of recurrent intracranial malignancy from radiation necrosis.
    Q J Nucl Med Mol Imaging Volume: 66 Page(s): 74 - 81
    03/01/2022 Authors: Parent EE; Sethi I; Nye J; Holder C; Olson JJ; Switchenko J; Tade F; Akin-Akintayo OO; Abiodun-Ojo OA; Akintayo A
  • Incidental Spinal Meningioma on an 18F-Fluciclovine PET/CT.
    Clin Nucl Med Volume: 47 Page(s): e313 - e314
    03/01/2022 Authors: Marcus C; Baugnon K; Schuster DM
  • Prostate and dominant intraprostatic lesion segmentation on PET/CT using cascaded regional-net.
    Phys Med Biol Volume: 66
    12/07/2021 Authors: Matkovic LA; Wang T; Lei Y; Akin-Akintayo OO; Abiodun Ojo OA; Akintayo AA; Roper J; Bradley JD; Liu T; Schuster DM
  • Improved Tumor Response in Patients on Metformin Undergoing Yttrium-90 Radioembolization Segmentectomy for Hepatocellular Carcinoma.
    Cardiovasc Intervent Radiol Volume: 44 Page(s): 1937 - 1944
    12/01/2021 Authors: Elsayed M; Wagstaff W; Behbahani K; Villalobos A; Bercu Z; Majdalany BS; Akce M; Schuster DM; Mao H; Kokabi N
  • 18F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic review.
    Prostate Cancer Prostatic Dis Volume: 24 Page(s): 997 - 1006
    12/01/2021 Authors: Rais-Bahrami S; Efstathiou JA; Turnbull CM; Camper SB; Kenwright A; Schuster DM; Scarsbrook AF
  • Randomized Trial of Conventional vs Conventional Plus Fluciclovine (18F) PET/CT-Guided Post-Prostatectomy Radiotherapy for Prostate Cancer: Volumetric and Patient-Reported Toxicity Analyses.
    Int J Radiat Oncol Biol Phys Volume: 111 Page(s): e271 - e272
    11/01/2021 Authors: Dhere VR; Schuster DM; Goyal S; Schreibmann E; Hershatter B; Rossi PJ; Shelton JW; Patel PR; Jani A
  • Feasibility of Using FDG in the Stereotactic Ablative Setting for Tracked Dose Delivery With BgRT: Results from a Prospective Study of Serial Inter-Fraction PET/CTs.
    Int J Radiat Oncol Biol Phys Volume: 111 Page(s): S97
    11/01/2021 Authors: Da Silva A; Olcott P; Tian S; Yang X; Sethi I; Shirvani SM; Mazin S; Owonikoko TK; Bradley JD; Schuster DM
  • Role of Resin Microsphere Y90 Dosimetry in Predicting Objective Tumor Response, Survival and Treatment Related Toxicity in Surgically Unresectable Colorectal Liver Metastasis: A Retrospective Single Institution Study.
    Cancers (Basel) Volume: 13
    09/29/2021 Authors: Sankhla T; Cheng B; Nezami N; Xing M; Sethi I; Bercu Z; Brandon D; Majdalany B; Schuster DM; Kokabi N
  • PET Imaging for Prostate Cancer.
    Radiol Clin North Am Volume: 59 Page(s): 801 - 811
    09/01/2021 Authors: Savir-Baruch B; Werner RA; Rowe SP; Schuster DM
  • Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on 18F-Fluciclovine PET/CT Guidance.
    J Nucl Med Volume: 62 Page(s): 1089 - 1096
    08/01/2021 Authors: Abiodun-Ojo OA; Jani AB; Akintayo AA; Akin-Akintayo OO; Odewole OA; Tade FI; Joshi SS; Master VA; Fielder B; Halkar RK
  • Determination of tumour dose response threshold and implication on survival in patients with HCC treated with Y90 radiation segmentectomy: a simple semi-quantitative analysis.
    Nucl Med Commun Volume: 42 Page(s): 892 - 898
    08/01/2021 Authors: Cheng B; Sethi I; Villalobos A; Wagstaff W; Schuster DM; Bercu Z; Brandon D; Kokabi N
  • Determination of Tumor Dose Response Thresholds in Patients with Chemorefractory Intrahepatic Cholangiocarcinoma Treated with Resin and Glass-based Y90 Radioembolization.
    Cardiovasc Intervent Radiol Volume: 44 Page(s): 1194 - 1203
    08/01/2021 Authors: Cheng B; Villalobos A; Sethi I; Wagstaff W; Galt J; Brandon D; Schuster DM; Bercu Z; Majdalany B; Kokabi N
  • Optimal Management of the Hyperkinetic Gallbladder: A Comparison of Outcomes Between Operative and Nonoperative Approaches.
    Am Surg Volume: 87 Page(s): 903 - 909
    06/01/2021 Authors: Williford ML; Fay KT; Simpson FJ; Defnet AM; Schuster DM; Sethi I; Lin E; Davis SS
  • 18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial.
    Lancet Volume: 397 Page(s): 1895 - 1904
    05/22/2021 Authors: Jani AB; Schreibmann E; Goyal S; Halkar R; Hershatter B; Rossi PJ; Shelton JW; Patel PR; Xu KM; Goodman M
  • Same day yttrium-90 radioembolization with single photon emission computed tomography/computed tomography: An opportunity to improve care during the COVID-19 pandemic and beyond.
    World J Gastrointest Oncol Volume: 13 Page(s): 440 - 452
    05/15/2021 Authors: Elsayed M; Loya M; Galt J; Schuster DM; Bercu ZL; Newsome J; Brandon D; Benenati S; Behbahani K; Duszak R
  • Positivity rates of F-18-fluciclovine PET/CT and Ga-68-PSMA PET/CT: Interim analysis of a secondary endpoint from a randomized trial in patients with biochemical recurrence post-prostatectomy
    Volume: 62
    05/01/2021 Authors: Abiodun-Ojo O; Jani A; Adediran O; Akintayo A; Fielder B; Goyal S; Halkar R; Schuster D
  • Tumor-to-Normal Ratio Relationship between Planning Technetium-99 Macroaggregated Albumin and Posttherapy Yttrium-90 Bremsstrahlung SPECT/CT.
    J Vasc Interv Radiol Volume: 32 Page(s): 752 - 760
    05/01/2021 Authors: Villalobos A; Cheng B; Wagstaff W; Sethi I; Bercu Z; Schuster DM; Brandon DC; Galt J; Kokabi N
  • Ring Sclerosis in Prostate Cancer: Circle of Malignancy or Benignity?
    Clin Nucl Med Volume: 46 Page(s): e286 - e289
    05/01/2021 Authors: Marcus C; Baum Y; Abiodun-Ojo OA; Jani AB; Schuster DM
  • Furosemide induced forced diuresis does not significantly impact Ga-68 PSMA-11 renal and urinary bladder activity and interpretative confidence
    Volume: 62
    05/01/2021 Authors: Parihar A; Satapathy S; Abiodun-Ojo O; Marcus C; Kumar R; Singh H; Bhattacharya A; Mittal B; Schuster D
  • Role of 18F-Fluciclovine and Prostate-Specific Membrane Antigen PET/CT in Guiding Management of Oligometastatic Prostate Cancer: AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol Volume: 216 Page(s): 851 - 859
    04/01/2021 Authors: Savir-Baruch B; Choyke PL; Rowe SP; Schuster DM; Subramaniam RM; Jadvar H
  • Prostate Cancer Liver Metastases Presenting as Relatively Photopenic Lesions on 18F-Fluciclovine PET/CT.
    Clin Nucl Med Volume: 46 Page(s): e240 - e241
    04/01/2021 Authors: Baiomy A; Martiniova L; Efstathiou E; Schuster DM; Ravizzini G
  • Yttrium-90 dosimetry and implications on tumour response and survival after radioembolisation of chemo-refractory hepatic metastases from breast cancer.
    Nucl Med Commun Volume: 42 Page(s): 402 - 409
    04/01/2021 Authors: Cheng B; Sethi I; Davisson N; Brandon D; Barron B; Galt J; Bercu Z; Schuster DM; Kokabi N
  • Using 18F-Fluciclovine PET/CT to Detect Prostate Cancer Recurrence in Patients With Very Low PSA Levels.
    AJR Am J Roentgenol Volume: 216 Page(s): W10
    03/01/2021 Authors: Siegel BA; Schuster DM; Savir-Baruch B
  • Comparison of Tc-99m MAA Planar Versus SPECT/CT Imaging for Lung Shunt Fraction Evaluation Prior to Y-90 Radioembolization: Are We Overestimating Lung Shunt Fraction?
    Cardiovasc Intervent Radiol Volume: 44 Page(s): 254 - 260
    02/01/2021 Authors: Elsayed M; Cheng B; Xing M; Sethi I; Brandon D; Schuster DM; Bercu Z; Galt J; Barron B; Kokabi N
  • Clinical utility of 18F-Fluciclovine PET/CT in recurrent prostate cancer with very low (0.3 ng/mL) prostate-specific antigen levels.
    Am J Nucl Med Mol Imaging Volume: 11 Page(s): 406 - 414
    01/01/2021 Authors: Marcus C; Abiodun-Ojo OA; Jani AB; Schuster DM
  • Exploratory study of 18F-fluciclovine pet/ct for response assessment to docetaxel in patients with metastatic castration-resistant prostate cancer.
    Am J Nucl Med Mol Imaging Volume: 11 Page(s): 218 - 229
    01/01/2021 Authors: Akintayo AA; Bilen MA; Abiodun-Ojo OA; Kucuk O; Carthon B; Chen Z; Jani AB; Parent EE; Schuster DM
  • [18F]-Fluciclovine PET discrimination of recurrent intracranial metastatic disease from radiation necrosis.
    EJNMMI Res Volume: 10 Page(s): 148
    12/07/2020 Authors: Parent EE; Patel D; Nye JA; Li Z; Olson JJ; Schuster DM; Goodman MM
  • Initial Report of a Randomized Trial Comparing Conventional- vs Conventional plus Fluciclovine (18F) PET/CT Imaging-Guided Post-Prostatectomy Radiotherapy for Prostate Cancer.
    Volume: 108 Page(s): 1397
    12/01/2020 Authors: Jani A; Schreibmann E; Goyal S; Raghuveer H; Hershatter B; Rossi PJ; Shelton JW; Patel PR; Xu KM; Goodman M
  • Erratum: Yttrium-90 Radioembolization Dosimetry: What Trainees Need to Know.
    Semin Intervent Radiol Volume: 37 Page(s): 1
    12/01/2020 Authors: Villalobos A; Soliman MM; Majdalany BS; Schuster DM; Galt J; Bercu ZL; Kokabi N
  • Yttrium-90 Radioembolization Dosimetry: What Trainees Need to Know.
    Semin Intervent Radiol Volume: 37 Page(s): 543 - 554
    12/01/2020 Authors: Villalobos A; Soliman MM; Majdalany BS; Schuster DM; Galt J; Bercu ZL; Kokabi N
  • Incidental Detection of Lung Adenocarcinoma Presenting as an Anterior Mediastinal Mass on 18F-Fluciclovine PET/CT in a Patient With Primary Prostate Cancer.
    Clin Nucl Med Volume: 45 Page(s): e525 - e527
    12/01/2020 Authors: Abiodun-Ojo OA; Akintayo AA; Sica GL; Alemozaffar M; Schuster DM
  • Simultaneous Integrated Boost of Lung Tumors in the Stereotactic Ablative Setting using BgRT Tracked Delivery
    Volume: 108 Page(s): E306 - E306
    11/01/2020 Authors: Olcott P; Shirvani SM; Tian S; Sethi I; Yang X; Da Silva A; Huntzinger C; Mazin S; Owonikoko TK; Schuster DM
  • Increased 18F-FDG Metabolic Activity during Lung SBRT Predicts Risk of Disease Progression: Results from a Prospective Study of Serial Inter-Fraction PET/CTs
    Volume: 108 Page(s): S59 - S60
    11/01/2020 Authors: Tian S; Switchenko J; Yang X; Sethi I; Da Silva A; Huntzinger C; Shirvani S; Owonikoko TK; Schuster DM; Curran WJ
  • ACR Appropriateness Criteria Recurrent Lower Urinary Tract Infections in Females.
    J Am Coll Radiol Volume: 17 Page(s): S487 - S496
    11/01/2020 Authors: Expert Panel on Urological Imaging; Venkatesan AM; Oto A; Allen BC; Akin O; Alexander LF; Chong J; Froemming AT; Fulgham PF; Goldfarb S
  • [18F]Fluciclovine Positron Emission Tomography/Computerized Tomography for Preoperative Staging in Patients with Intermediate to High Risk Primary Prostate Cancer.
    J Urol Volume: 204 Page(s): 734 - 740
    10/01/2020 Authors: Alemozaffar M; Akintayo AA; Abiodun-Ojo OA; Patil D; Saeed F; Huang Y; Osunkoya AO; Goodman MM; Sanda M; Schuster DM
  • [18F]fluciclovine PET/CT versus multiparametric MRI assessment of seminal vesicle invasion and extracapsular extension in patients with primary prostate cancer.
    Volume: 61
    05/01/2020 Authors: Akintayo A; Abiodun-Ojo O; Alemozaffar M; Akin-Akintayo O; Patil D; Huang Y; Osunkoya A; Sanda M; Schuster D
  • 18F-fluciclovine PET/CT findings are predictive of failure-free survival following salvage radiotherapy in post-prostatectomy patients with biochemical recurrence.
    Volume: 61
    05/01/2020 Authors: Abiodun-Ojo O; Jani A; Akintayo A; Alemozaffar M; Akin-Akintayo O; Tade F; Master V; Patel P; Shelton J; Kucuk O
  • PREOPERATIVE F-18-FLUCICLOVINE PET/CT FINDINGS MAY BE PREDICTIVE OF POST-OPERATIVE PROSTATE-SPECIFIC ANTIGEN (PSA) IN PATIENTS WITH HIGH RISK PROSTATE CANCER
    Volume: 203 Page(s): E1026 - E1026
    04/01/2020 Authors: Akintayo A; Abiodun-Ojo O; Alemozaffar M; Akin-Akintayo O; Patil D; Osunkoya A; Sanda M; Schuster D
  • [18F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging-version 1.0.
    Eur J Nucl Med Mol Imaging Volume: 47 Page(s): 579 - 591
    03/01/2020 Authors: Nanni C; Zanoni L; Bach-Gansmo T; Minn H; Willoch F; Bogsrud TV; Edward EP; Savir-Baruch B; Teoh E; Ingram F
  • Characterizing and Mitigating Bladder Radioactivity on 18F-Fluciclovine PET/CT.
    J Nucl Med Technol Volume: 48 Page(s): 24 - 29
    03/01/2020 Authors: Lovrec P; Schuster DM; Wagner RH; Gabriel M; Savir-Baruch B
  • The role of 68Ga-DOTATATE for evaluation of patients with metastatic castration- resistant prostate cancer (mCRPC)
    Volume: 38
    02/20/2020 Authors: Bilen MA; Akintayo AA; Abiodun-Ojo OA; Kucuk O; Carthon BC; Schuster DM; Parent EE
  • Male pelvic multi-organ segmentation aided by CBCT-based synthetic MRI.
    Phys Med Biol Volume: 65 Page(s): 035013
    02/04/2020 Authors: Lei Y; Wang T; Tian S; Dong X; Jani AB; Schuster D; Curran WJ; Patel P; Liu T; Yang X
  • Incidence of Radioembolization-Induced Liver Disease and Liver Toxicity Following Repeat 90Y-Radioembolization: Outcomes at a Large Tertiary Care Center.
    Clin Nucl Med Volume: 45 Page(s): 100 - 104
    02/01/2020 Authors: Elsayed M; Ermentrout RM; Sethi I; Bercu ZL; Galt JR; Whitmore M; Brandon DC; Schuster DM; Kokabi N
  • 18F-Fluciclovine Positron Emission Tomography in Men With Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy and Planning to Undergo Salvage Radiation Therapy: Results from LOCATE.
    Pract Radiat Oncol Volume: 10 Page(s): 354 - 362
    01/01/2020 Authors: Solanki AA; Savir-Baruch B; Liauw SL; Michalski J; Tward JD; Vapiwala N; Teoh EJ; LOCATE study group
  • ACR Appropriateness Criteria Lower Urinary Tract Symptoms-Suspicion of Benign Prostatic Hyperplasia.
    J Am Coll Radiol Volume: 16 Page(s): S378 - S383
    11/01/2019 Authors: Expert Panel on Urological Imaging; Alexander LF; Oto A; Allen BC; Akin O; Chong J; Froemming AT; Fulgham PF; Goldfarb S; Maranchie JK
  • 18F-Fluciclovine Parameters on Targeted Prostate Biopsy Associated with True Positivity in Recurrent Prostate Cancer.
    J Nucl Med Volume: 60 Page(s): 1531 - 1536
    11/01/2019 Authors: Abiodun-Ojo OA; Akintayo AA; Akin-Akintayo OO; Tade FI; Nieh PT; Master VA; Alemozaffar M; Osunkoya AO; Goodman MM; Fei B
  • Evaluation of Utility of Low Dose Yttrium-90 for Radioembolization Treatment Planning Using SPECT/CT and PET/CT - A phantom study
    Volume: 46 Page(s): S259 - S259
    10/01/2019 Authors: Kokabi N; Sethi I; Mir D; Schuster DM; Lee JS; Kappadath S; Risk B; Galt JR
  • Feasibility of Hyperfunctioning Parathyroid Gland Localization Using [18F]fluciclovine PET/CT.
    Mol Imaging Biol Volume: 21 Page(s): 818 - 824
    10/01/2019 Authors: Akintayo AA; Abiodun-Ojo OA; Weber C; Sharma J; Cohen C; Sica G; Halkar R; Goodman MM; Schuster DM
  • Inter-Fraction Variability of 18-FDG PET During Lung SBRT and the Effect of Systemic and Immunotherapy: Results of a Prospective Pilot Study
    Volume: 14 Page(s): S607 - S608
    10/01/2019 Authors: Tian S; Switchenko J; Sethi I; Yang X; Da Silva A; Owonikoko T; Schuster D; Curran W; Higgins K
  • Fluorine-18-Labeled Fluciclovine PET/CT in Clinical Practice: Factors Affecting the Rate of Detection of Recurrent Prostate Cancer.
    AJR Am J Roentgenol Volume: 213 Page(s): 851 - 858
    10/01/2019 Authors: Savir-Baruch B; Lovrec P; Solanki AA; Adams WH; Yonover PM; Gupta G; Schuster DM
  • Role of novel imaging in the management of prostate cancer.
    Urol Oncol Volume: 37 Page(s): 611 - 618
    09/01/2019 Authors: Xu KM; Chen RC; Schuster DM; Jani AB
  • Feasibility and Initial Results: Fluciclovine Positron Emission Tomography/Ultrasound Fusion Targeted Biopsy of Recurrent Prostate Cancer.
    J Urol Volume: 202 Page(s): 413 - 421
    08/01/2019 Authors: Fei B; Abiodun-Ojo OA; Akintayo AA; Akin-Akintayo O; Tade F; Nieh PT; Master VA; Alemozaffar M; Osunkoya AO; Goodman MM
  • [F-18] fluciclovine PET/CT is superior to conventional imaging in preoperative nodal staging in patients with high-risk prostate cancer
    Volume: 60
    05/01/2019 Authors: Akintayo A; Abiodun-Ojo O; Alemozaffar M; Osunkoya A; Sanda M; Schuster D
  • Preoperative staging in high risk prostate cancer patients using F-18] fluctclovine PET/CT
    Volume: 60
    05/01/2019 Authors: Akintayo A; Abiodun-Ojo O; Alemozaffar M; Osunkoya A; Sanda M; Schuster D
  • [F-18]-fluciclovine positivity rate is not affected by androgen deprivation therapy (ADT) in recurrent prostate cancer post-prostatectomy.
    Volume: 60
    05/01/2019 Authors: Abiodun-Ojo O; Jani A; Akintayo A; Alemozaffar M; Akin-Akintayo O; Odewole O; Tade F; Nieh P; Master V; Patel P
  • Safety and effectiveness of F-18-fluciclovine PET in adults with recurrent glioma: A retrospective observational study
    Volume: 60
    05/01/2019 Authors: Bach-Gansmo T; Michaud L; Parent E; Akintayo A; Stevens D; Chau A; Dunphy M; Blasberg R; Schuster D; Goodman M
  • Deep learning-based three-dimensional segmentation of the prostate on computed tomography images.
    J Med Imaging (Bellingham) Volume: 6 Page(s): 025003
    04/01/2019 Authors: Shahedi M; Halicek M; Dormer JD; Schuster DM; Fei B
  • EVALUATION OF FLUCICLOVINE (FACBC) PET SCAN FOR STAGING HIGH-RISK PROSTATE CANCER BEFORE PRIMARY TREATMENT
    Volume: 201 Page(s): E396 - E396
    04/01/2019 Authors: Alemozaffar M; Akintayo A; Abiodun-Ojo O; Huang E; Patil D; Giles S; Torlak M; Sanda M; Schuster D
  • Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0.
    Eur J Nucl Med Mol Imaging Volume: 46 Page(s): 540 - 557
    03/01/2019 Authors: Law I; Albert NL; Arbizu J; Boellaard R; Drzezga A; Galldiks N; la Fougre C; Langen K-J; Lopci E; Lowe V
  • Fluciclovine (18F) PET Detection of Lymph Node Metastasis in High-risk Primary Prostatic Adenocarcinoma Patients
    Volume: 32
    03/01/2019 Authors: Saeed F; Abiodun-Ojo O; Akintayo A; Alemozaffar M; Schuster D; Osunkoya AO
  • Fluciclovine (18F) PET Detection of Lymph Node Metastasis in High-risk Primary Prostatic Adenocarcinoma Patients
    Volume: 99
    03/01/2019 Authors: Saeed F; Abiodun-Ojo O; Akintayo A; Alemozaffar M; Schuster D; Osunkoya AO
  • A semiautomatic approach for prostate segmentation in MR images using local texture classification and statistical shape modeling.
    Proc SPIE Int Soc Opt Eng Volume: 10951
    02/01/2019 Authors: Shahedi M; Halicek M; Li Q; Liu L; Zhang Z; Verma S; Schuster DM; Fei B
  • The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial.
    J Urol Volume: 201 Page(s): 322 - 331
    02/01/2019 Authors: Andriole GL; Kostakoglu L; Chau A; Duan F; Mahmood U; Mankoff DA; Schuster DM; Siegel BA; LOCATE Study Group
  • ACR-ACNM Practice Parameter for the Performance of Fluorine-18 Fluciclovine-PET/CT for Recurrent Prostate Cancer.
    Clin Nucl Med Volume: 43 Page(s): 909 - 917
    12/01/2018 Authors: Savir-Baruch B; Banks KP; McConathy JE; Molchanova-Cook OP; Parent EE; Takalkar A; Tulchinsky M; Yu JQ; Subramaniam RM; Schuster DM
  • Design and Evaluation of a Semi-Automated Algorithm for Segmentation of Anti-[18F]FACBC (Fluciclovine F18) PET Images for Post-Prostatectomy Radiation Therapy
    Volume: 102 Page(s): E561 - E561
    11/01/2018 Authors: Schreibmann E; Schuster DM; Patel PR; Shelton JW; Cooper S; Raghuveer H; Jani A
  • Current Clinical Practice Patterns of Self-Identified Nuclear Medicine Specialists.
    AJR Am J Roentgenol Volume: 211 Page(s): 978 - 985
    11/01/2018 Authors: Balthazar P; Schuster DM; Grady EE; Rosenkrantz AB; Duszak R
  • Selective modification of fluciclovine (18F) transport in prostate carcinoma xenografts.
    Amino Acids Volume: 50 Page(s): 1301 - 1305
    09/01/2018 Authors: Tade FI; Wiles WG; Lu G; Bilir B; Akin-Akintayo O; Lee JS; Patil D; Yu W; Ormenisan Gherasim C; Fei B
  • Imaging of Prostate Cancer Using Fluciclovine.
    Urol Clin North Am Volume: 45 Page(s): 489 - 502
    08/01/2018 Authors: Savir-Baruch B; Zanoni L; Schuster DM
  • [18F]Fluciclovine PET discrimination between high- and low-grade gliomas.
    EJNMMI Res Volume: 8 Page(s): 67
    07/25/2018 Authors: Parent EE; Benayoun M; Ibeanu I; Olson JJ; Hadjipanayis CG; Brat DJ; Adhikarla V; Nye J; Schuster DM; Goodman MM
  • Amino Acid Metabolism as a Target for Breast Cancer Imaging.
    PET Clin Volume: 13 Page(s): 437 - 444
    07/01/2018 Authors: Ulaner GA; Schuster DM
  • A semiautomatic segmentation method for prostate in CT images using local texture classification and statistical shape modeling.
    Med Phys Volume: 45 Page(s): 2527 - 2541
    06/01/2018 Authors: Shahedi M; Halicek M; Guo R; Zhang G; Schuster DM; Fei B
  • Pearls And Pitfalls Of Bone Lesions In F18-Flucicluvine PET/CT
    Volume: 59
    05/01/2018 Authors: Baum Y; Schuster D
  • Fluciclovine PET Imaging of Intracranial Metastases
    Volume: 59
    05/01/2018 Authors: Patel D; Nye J; Schuster D; Olson J; Goodman M; Parent E
  • The role of fluciclovine (F-18) PET/CT directed, 3D ultrasound-guided fusion targeted biopsy in the detection of biochemically recurrent prostate cancer
    Volume: 59
    05/01/2018 Authors: Abiodun-Ojo O; Fei B; Nieh P; Master V; Akintayo A; Tade F; Akin-Akintayo O; Alemozaffar M; Osunkoya A; Goodman M
  • ACR Appropriateness Criteria PretreatmentStaging of Muscle-Invasive BladderCancer.
    J Am Coll Radiol Volume: 15 Page(s): S150 - S159
    05/01/2018 Authors: Expert Panel on Urologic Imaging:; van der Pol CB; Sahni VA; Eberhardt SC; Oto A; Akin O; Alexander LF; Allen BC; Coakley FV; Froemming AT
  • ACR Appropriateness Criteria Post-treatmentFollow-up Prostate Cancer.
    J Am Coll Radiol Volume: 15 Page(s): S132 - S149
    05/01/2018 Authors: Expert Panel on Urologic Imaging:; Froemming AT; Verma S; Eberhardt SC; Oto A; Alexander LF; Allen BC; Coakley FV; Davis BJ; Fulgham PF
  • Update on 18F-Fluciclovine PET for Prostate Cancer Imaging.
    J Nucl Med Volume: 59 Page(s): 733 - 739
    05/01/2018 Authors: Parent EE; Schuster DM
  • Prospective evaluation of fluciclovine (18F) PET-CT and MRI in detection of recurrent prostate cancer in non-prostatectomy patients.
    Eur J Radiol Volume: 102 Page(s): 1 - 8
    05/01/2018 Authors: Akin-Akintayo O; Tade F; Mittal P; Moreno C; Nieh PT; Rossi P; Patil D; Halkar R; Fei B; Master V
  • Bayesian penalised likelihood reconstruction (Q.Clear) of 18F-fluciclovine PET for imaging of recurrent prostate cancer: semi-quantitative and clinical evaluation.
    Br J Radiol Volume: 91 Page(s): 20170727
    05/01/2018 Authors: Teoh EJ; McGowan DR; Schuster DM; Tsakok MT; Gleeson FV; Bradley KM
  • 90Y radioembolization dosimetry using a simple semi-quantitative method in intrahepatic cholangiocarcinoma: Glass versus resin microspheres.
    Nucl Med Biol Volume: 59 Page(s): 22 - 28
    04/01/2018 Authors: Nezami N; Kokabi N; Camacho JC; Schuster DM; Xing M; Kim HS
  • A semiautomatic algorithm for three-dimensional segmentation of the prostate on CT images using shape and local texture characteristics.
    Proc SPIE Int Soc Opt Eng Volume: 10576
    02/01/2018 Authors: Shahedi M; Ma L; Halicek M; Guo R; Zhang G; Schuster DM; Nieh P; Master V; Fei B
  • A combined learning algorithm for prostate segmentation on 3D CT images.
    Med Phys Volume: 44 Page(s): 5768 - 5781
    11/01/2017 Authors: Ma L; Guo R; Zhang G; Schuster DM; Fei B
  • PET Molecular Imaging-Directed Biopsy: A Review.
    AJR Am J Roentgenol Volume: 209 Page(s): 255 - 269
    08/01/2017 Authors: Fei B; Schuster DM
  • ACR Appropriateness Criteria Prostate Cancer-Pretreatment Detection, Surveillance, andStaging.
    J Am Coll Radiol Volume: 14 Page(s): S245 - S257
    05/01/2017 Authors: Expert Panel on Urologic Imaging:; Coakley FV; Oto A; Alexander LF; Allen BC; Davis BJ; Froemming AT; Fulgham PF; Hosseinzadeh K; Porter C
  • PET/Ultrasound fusion targeted biopsy of the prostate: initial clinical results
    Volume: 58
    05/01/2017 Authors: Fei B; Nieh P; Master V; Alemozaffar M; Tade F; Akin-Akintayo O; Osunkoya A; Goodman M; Schuster D
  • Bayesian penalised likelihood reconstruction of fluciclovine (F-18) PET for imaging of recurrent prostate cancer: semi-quantitative and clinical evaluation
    Volume: 58
    05/01/2017 Authors: Teoh E; McGowan D; Schuster D; Tsakok M; Gleeson F; Bradley K
  • Fasting Enhances the Contrast of Bone Metastatic Lesions in 18F-Fluciclovine-PET: Preclinical Study Using a Rat Model of Mixed Osteolytic/Osteoblastic Bone Metastases.
    Int J Mol Sci Volume: 18
    04/29/2017 Authors: Oka S; Kanagawa M; Doi Y; Schuster DM; Goodman MM; Yoshimura H
  • COMPARISON OF FLUCICLOVINE (18F) PET-CT AND MRI IN DETECTION OF RECURRENT PROSTATE CANCER
    Volume: 197 Page(s): E222 - E223
    04/01/2017 Authors: Akin-Akintayo O; Tade F; Mittal P; Moreno C; Nieh P; Rossi P; Raghuveer H; Fei B; Goodman M; Schuster D
  • Imaging of Prostate Cancer Using Fluciclovine.
    PET Clin Volume: 12 Page(s): 145 - 157
    04/01/2017 Authors: Savir-Baruch B; Zanoni L; Schuster DM
  • Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (18F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate Cancer.
    J Urol Volume: 197 Page(s): 676 - 683
    03/01/2017 Authors: Bach-Gansmo T; Nanni C; Nieh PT; Zanoni L; Bogsrud TV; Sletten H; Korsan KA; Kieboom J; Tade FI; Odewole O
  • Impact of 18F-Fluciclovine PET on Target Volume Definition for Postprostatectomy Salvage Radiotherapy: Initial Findings from a Randomized Trial.
    J Nucl Med Volume: 58 Page(s): 412 - 418
    03/01/2017 Authors: Jani AB; Schreibmann E; Rossi PJ; Shelton J; Godette K; Nieh P; Master VA; Kucuk O; Goodman M; Halkar R
  • Multisite experience of fluciclovine (F-18) PET/CT imaging in biochemically recurrent prostate cancer: Impact of clinical factors and intersite variation.
    Volume: 35
    02/20/2017 Authors: Zanoni L; Nanni C; Bach-Gansmo T; Bogsrud TV; Nieh P; Kieboom J
  • Automatic segmentation of the prostate on CT images using deep learning and multi-atlas fusion.
    Proc SPIE Int Soc Opt Eng Volume: 10133
    02/01/2017 Authors: Ma L; Guo R; Zhang G; Tade F; Schuster DM; Nieh P; Master V; Fei B
  • Does Injection of 2-Aminobicyclo-(2,2,1)-Heptane-2-Carboxylic Acid (BCH) Affect Amino Acid Transporter Density in Prostate Cancer Xenografts?
    Volume: 30 Page(s): 247A - 247A
    02/01/2017 Authors: Ormenisan-Gherasim C; Tade F; Akin-Akintayo OO; Bilir B; Wiles WG; Lu G; Fei B; Moreno CS; Goodman MM; Schuster DM
  • Does Injection of 2-Aminobicyclo-(2,2,1)-Heptane-2-Carboxylic Acid (BCH) Affect Amino Acid Transporter Density in Prostate Cancer Xenografts?
    Volume: 97 Page(s): 247A - 247A
    02/01/2017 Authors: Ormenisan-Gherasim C; Tade F; Akin-Akintayo OO; Bilir B; Wiles WG; Lu G; Fei B; Moreno CS; Goodman MM; Schuster DM
  • Re: "Cost-Savings Analysis of Renal Scintigraphy, Stratified byRenal Function Thresholds: Mercaptoacetyltriglycine Versus Diethylene Triamine Penta-Acetic Acid".
    J Am Coll Radiol Volume: 14 Page(s): 146
    02/01/2017 Authors: Taylor AT; Schuster DM
  • Molecular imaging and fusion targeted biopsy of the prostate.
    Clin Transl Imaging Volume: 5 Page(s): 29 - 43
    02/01/2017 Authors: Fei B; Nieh PT; Master VA; Zhang Y; Osunkoya AO; Schuster DM
  • Head and neck PET/CT therapy response interpretation criteria (Hopkins criteria) - external validation study.
    Am J Nucl Med Mol Imaging Volume: 7 Page(s): 174 - 180
    01/01/2017 Authors: Kendi AT; Brandon D; Switchenko J; Wadsworth JT; El-Deiry MW; Saba NF; Schuster DM; Subramaniam RM
  • PET Tracer 18F-Fluciclovine Can Detect Histologically Proven Bone Metastatic Lesions: A Preclinical Study in Rat Osteolytic and Osteoblastic Bone Metastasis Models.
    Theranostics Volume: 7 Page(s): 2048 - 2064
    01/01/2017 Authors: Oka S; Kanagawa M; Doi Y; Schuster DM; Goodman MM; Yoshimura H
  • Radionuclide Therapies in Molecular Imaging and Precision Medicine.
    PET Clin Volume: 12 Page(s): 93 - 103
    01/01/2017 Authors: Kendi AT; Moncayo VM; Nye JA; Galt JR; Halkar R; Schuster DM
  • Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate Cancer.
    Clin Nucl Med Volume: 42 Page(s): e22 - e28
    01/01/2017 Authors: Akin-Akintayo OO; Jani AB; Odewole O; Tade FI; Nieh PT; Master VA; Bellamy LM; Halkar RK; Zhang C; Chen Z
  • PET Tracers Beyond FDG in Prostate Cancer.
    Semin Nucl Med Volume: 46 Page(s): 507 - 521
    11/01/2016 Authors: Schuster DM; Nanni C; Fanti S
  • Staging of Biochemically Relapsing Prostate Cancer Using the Positron Emission Tomography Tracer Fluciclovine F18
    Volume: 96 Page(s): S112 - S112
    10/01/2016 Authors: Bach-Gansmo T; Nanni C; Nieh P; Zanoni L; Bogsrud T; Sletten H; Korsan K; Kieboom J; Chau A; Ward P
  • Evaluation of Prostate Cancer with Radiolabeled Amino Acid Analogs.
    J Nucl Med Volume: 57 Page(s): 61S - 66S
    10/01/2016 Authors: Schuster DM; Nanni C; Fanti S
  • Staging of Biochemically Relapsing Prostate Cancer Using the Positron Emission Tomography Tracer Fluciclovine F18.
    Int J Radiat Oncol Biol Phys Volume: 96 Page(s): S112
    10/01/2016 Authors: Bach-Gansmo T; Nanni C; Nieh P; Zanoni L; Bogsrud T; Sletten H; Korsan K; Kieboom J; Chau A; Ward P
  • Image Guided Planning for Prostate Carcinomas With Incorporation of Anti-3-[18F]FACBC (Fluciclovine) Positron Emission Tomography: Workflow and Initial Findings From a Randomized Trial.
    Int J Radiat Oncol Biol Phys Volume: 96 Page(s): 206 - 213
    09/01/2016 Authors: Schreibmann E; Schuster DM; Rossi PJ; Shelton J; Cooper S; Jani AB
  • Is There a Role for PET/CT Parameters to Characterize Benign, Malignant, and Metastatic Parotid Tumors?
    AJR Am J Roentgenol Volume: 207 Page(s): 635 - 640
    09/01/2016 Authors: Kendi ATK; Magliocca KR; Corey A; Galt JR; Switchenko J; Wadsworth JT; El-Deiry MW; Schuster DM; Saba NF; Hudgins PA
  • Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT.
    Eur J Nucl Med Mol Imaging Volume: 43 Page(s): 1773 - 1783
    09/01/2016 Authors: Odewole OA; Tade FI; Nieh PT; Savir-Baruch B; Jani AB; Master VA; Rossi PJ; Halkar RK; Osunkoya AO; Akin-Akintayo O
  • Anti-3-18F-FACBC (18F-Fluciclovine) PET/CT of Breast Cancer: An Exploratory Study.
    J Nucl Med Volume: 57 Page(s): 1357 - 1363
    09/01/2016 Authors: Tade FI; Cohen MA; Styblo TM; Odewole OA; Holbrook AI; Newell MS; Savir-Baruch B; Li X; Goodman MM; Nye JA
  • Focal Hepatic Hot Spot From Superior Vena Cava Occlusion Visualized on Ventilation/Perfusion Scintigraphy With Contrast-Enhanced CT Correlate.
    Clin Nucl Med Volume: 41 Page(s): 401 - 402
    05/01/2016 Authors: Lawrence M; Schuster DM
  • External Validation of Therapy Response Interpretation Criteria (Hopkins Criteria) with inter-reader reliability, accuracy and Progression free survival outcomes
    JOURNAL OF NUCLEAR MEDICINE Volume: 57
    05/01/2016 Authors: Kendi ATK; Brandon D; Switchenko J; Wadsworth J; El-Deiry M; Saba N; Schuster D; Subramaniam R
  • Feasibility of Fluciclovine (FACBC) for bone metastasis diagnosis in prostate and breast cancer: Evaluation by using triple-tracer autoradiography with 14C-Fluciclovine/3H-FDG/99mTc-HMDP in rat osteolytic/osteoblastic bone metastasis models
    JOURNAL OF NUCLEAR MEDICINE Volume: 57
    05/01/2016 Authors: Oka S; Kanagawa M; Ono M; Doi Y; Schuster D; Goodman M; Yoshimura H
  • IMPACT OF INTRINSIC AND EXTRINSIC FACTORS ON THE DETECTION RATE OF THE PET TRACER FLUCICLOVINE (18F) IN BIOCHEMICAL RELAPSE OF PROSTATE CANCER: A MULTI-INSTITUTIONAL EXPERIENCE
    Volume: 195 Page(s): E1041 - E1042
    04/01/2016 Authors: Bogsrud TV; Nanni C; Nieh P; Zanoni L; Bach-Gansmo T; Sletten H; Koren K; Kieboom J; Chau A; Ward P
  • Random Walk Based Segmentation for the Prostate on 3D Transrectal Ultrasound Images.
    Proc SPIE Int Soc Opt Eng Volume: 9786
    02/27/2016 Authors: Ma L; Guo R; Tian Z; Venkataraman R; Sarkar S; Liu X; Nieh PT; Master VV; Schuster DM; Fei B
  • Combining Population and Patient-Specific Characteristics for Prostate Segmentation on 3D CT Images.
    Volume: 9784
    02/27/2016 Authors: Ma L; Guo R; Tian Z; Venkataraman R; Sarkar S; Liu X; Tade F; Schuster DM; Fei B
  • Is there a role for PET/CT parameters to differentiate thyroid cartilage invasion from penetration?
    Eur J Radiol Volume: 85 Page(s): 319 - 323
    02/01/2016 Authors: Kendi AT; Corey A; Magliocca KR; Galt JR; Zhang C; Chen Z; Higgins K; Beitler JJ; Wadsworth JT; El-Deiry MW
  • 90Y Radioembolization Lung Shunt Fraction in Primary and Metastatic Liver Cancer as a Biomarker for Survival.
    Clin Nucl Med Volume: 41 Page(s): 21 - 27
    01/01/2016 Authors: Xing M; Lahti S; Kokabi N; Schuster DM; Camacho JC; Kim HS
  • TRANSPORT MECHANISM OF THE AMINO ACID POSITRON EMISSION TOMOGRAPHY TRACER [F-18] FLUCICLOVINE AND ITS APPLICATION TO GLIOMA DIAGNOSIS
    Volume: 47 Page(s): 249 - 249
    11/20/2015 Authors: Ono M; Doi Y; Oka S; Okudaira H; Schuster DM; Goodman MM; Matsumoto H; Kawai K; Shirakami Y
  • Image Guided Planning for Prostate Carcinomas With Incorporation of Anti-3-[18F]FACBC Positron Emission Tomography: Workflow and Initial Findings
    Volume: 93 Page(s): E554 - E554
    11/01/2015 Authors: Schreibmann E; Schuster DM; Rossi PJ; Shelton JW; Cooper S; Goodman M; Halkar R; Funmilayo T; Odewole O; Jani A
  • Impact of Anti-3-[18F]FACBC Positron Emission Tomography on Target Volume Definition After Prostatectomy: Initial Findings From a Randomized Trial
    Volume: 93 Page(s): S135 - S135
    11/01/2015 Authors: Jani A; Schreibmann E; Rossi PJ; Shelton JW; Godette KD; Nieh P; Master VA; Kucuk O; Goodman M; Halkar R
  • [(14)C]Fluciclovine (alias anti-[(14)C]FACBC) uptake and ASCT2 expression in castration-resistant prostate cancer cells.
    Nucl Med Biol Volume: 42 Page(s): 887 - 892
    11/01/2015 Authors: Ono M; Oka S; Okudaira H; Nakanishi T; Mizokami A; Kobayashi M; Schuster DM; Goodman MM; Shirakami Y; Kawai K
  • Octreoscan Versus FDG-PET for Neuroendocrine Tumor Staging: A Biological Approach.
    Volume: 22 Page(s): 2295 - 2301
    07/01/2015 Authors: Squires MH; Volkan Adsay N; Schuster DM; Russell MC; Cardona K; Delman KA; Winer JH; Altinel D; Sarmiento JM; El-Rayes B
  • 18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers?
    Eur J Radiol Volume: 84 Page(s): 1171 - 1176
    06/01/2015 Authors: Kendi AT; Corey A; Magliocca KR; Nickleach DC; Galt J; Switchenko JM; El-Deiry MW; Wadsworth JT; Hudgins PA; Saba NF
  • The nuclear medicine therapy care coordination service: a model for radiologist-driven patient-centered care.
    Acad Radiol Volume: 22 Page(s): 771 - 778
    06/01/2015 Authors: Moncayo VM; Applegate KE; Duszak R; Barron BJ; Fitz J; Halkar RK; Lee DJ; Schuster DM
  • Anti-[F-18] FACBC (FACBC) PET-CT and multiparametric MR (mp-MR) imaging in the detection of recurrent prostate cancer
    Volume: 56
    05/01/2015 Authors: Tade F; Odewole O; Halkar R; Mittal P; Nieh P; Rossi P; Fei B; Savir-Baruch B; Goodman M; Schuster D
  • Preliminary findings of anti-[F-18] FACBC (FACBC) PET-CT imaging of breast cancer
    Volume: 56
    05/01/2015 Authors: Tade F; Odewole O; Cohen M; Styblo T; Li X; Holbrook A; Newell M; Savir-Baruch B; Goodman M; Schuster D
  • Change in salvage radiotherapy management based on guidance with anti-3-[F-18] FACBC PET-CT in recurrent prostate cancer patients post-prostatectomy.
    Volume: 56
    05/01/2015 Authors: Odewole O; Jani A; Tade F; Nieh P; Master V; Bellamy M; Goodman M; Halkar R; Schuster D
  • Corrigendum to "Kinetic analyses of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid transport in Xenopus laevis oocytes expressing human ASCT2 and SNAT2" (Nucl. Med. Biol. 2013;40:670-675).
    Nucl Med Biol Volume: 42 Page(s): 513 - 514
    05/01/2015 Authors: Okudaira H; Nakanishi T; Oka S; Kobayashi M; Tamagami H; Schuster DM; Goodman MM; Shirakami Y; Tamai I; Kawai K
  • Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaques.
    Nat Methods Volume: 12 Page(s): 427 - 432
    05/01/2015 Authors: Santangelo PJ; Rogers KA; Zurla C; Blanchard EL; Gumber S; Strait K; Connor-Stroud F; Schuster DM; Amancha PK; Hong JJ
  • Reproducibility and reliability of anti-3-[F]FACBC uptake measurements in background structures and malignant lesions on follow-up PET-CT in prostate carcinoma: an exploratory analysis.
    Mol Imaging Biol Volume: 17 Page(s): 277 - 283
    04/01/2015 Authors: Odewole OA; Oyenuga OA; Tade F; Savir-Baruch B; Nieh PT; Master V; Chen Z; Wang X; Jani AB; Bellamy LM
  • Do 18F-FDG PET/CT parameters in oropharyngeal and oral cavity squamous cell carcinomas indicate HPV status?
    Clin Nucl Med Volume: 40 Page(s): e196 - e200
    03/01/2015 Authors: Kendi ATK; Magliocca K; Corey A; Nickleach DC; Galt J; Higgins K; Beitler JJ; El-Deiry MW; Wadsworth JT; Hudgins PA
  • Molecular imaging of advanced prostate cancer.
    Curr Probl Cancer Volume: 39 Page(s): 29 - 32
    01/01/2015 Authors: Rossi PJ; Schuster DM
  • (90)Y Radioembolization: Multimodality Imaging Pattern Approach with Angiographic Correlation for Optimized Target Therapy Delivery.
    Radiographics Volume: 35 Page(s): 1602 - 1618
    01/01/2015 Authors: Camacho JC; Moncayo V; Kokabi N; Reavey HE; Galt JR; Yamada K; Kies DD; Williams RS; Kim HS; Schuster DM
  • Another "great mimicker": FDG-PET/CT imaging findings of sarcoid-like reaction.
    BJR Case Rep Volume: 1 Page(s): 20150060
    01/01/2015 Authors: Kendi ATK; Barron BJ; Bonta D; Halkar RK; Rathore B; Schuster DM
  • Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease.
    J Nucl Med Volume: 55 Page(s): 1986 - 1992
    12/01/2014 Authors: Schuster DM; Nanni C; Fanti S; Oka S; Okudaira H; Inoue Y; Srensen J; Owenius R; Choyke P; Turkbey B
  • Accumulation of trans-1-amino-3-[(18)F]fluorocyclobutanecarboxylic acid in prostate cancer due to androgen-induced expression of amino acid transporters.
    Mol Imaging Biol Volume: 16 Page(s): 756 - 764
    12/01/2014 Authors: Okudaira H; Oka S; Ono M; Nakanishi T; Schuster DM; Kobayashi M; Goodman MM; Tamai I; Kawai K; Shirakami Y
  • Four-dimensional (4D) motion detection to correct respiratory effects in treatment response assessment using molecular imaging biomarkers.
    Technol Cancer Res Treat Volume: 13 Page(s): 571 - 582
    12/01/2014 Authors: Schreibmann E; Crocker I; Schuster DM; Curran WJ; Fox T
  • PET response criteria for solid tumors predict survival at three months after intra-arterial resin-based 90Yttrium radioembolization therapy for unresectable intrahepatic cholangiocarcinoma.
    Clin Nucl Med Volume: 39 Page(s): 944 - 950
    11/01/2014 Authors: Camacho JC; Kokabi N; Xing M; Schuster DM; Kim HS
  • A rare presentation of myocardial plasmacytoma assessed by FDG PET/CT.
    Clin Nucl Med Volume: 39 Page(s): 643 - 645
    07/01/2014 Authors: Tong AKT; Mann KP; Schuster DM; Yan X
  • Differences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose.
    Mol Imaging Biol Volume: 16 Page(s): 322 - 329
    06/01/2014 Authors: Oka S; Okudaira H; Ono M; Schuster DM; Goodman MM; Kawai K; Shirakami Y
  • Reproducibility of anti-3-[18F]FACBC uptake in background structures and malignant lesions on followup PET-CT in prostate carcinoma: An exploratory analysis
    Volume: 55
    05/01/2014 Authors: Odewole O; Savir-Baruch B; Nieh P; Master V; Chen Z; Wang X; Jani A; Halkar R; Goodman M; Schuster D
  • Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial.
    J Urol Volume: 191 Page(s): 1446 - 1453
    05/01/2014 Authors: Schuster DM; Nieh PT; Jani AB; Amzat R; Bowman FD; Halkar RK; Master VA; Nye JA; Odewole OA; Osunkoya AO
  • Anti-1-amino-3-[18F] fluorocyclobutane-1-carboxylic acid (anti-3-[18F] FACBC): Normal physiology and variant patterns of uptake
    Volume: 55
    05/01/2014 Authors: Savir-Baruch B; Odewole O; Nye J; Master V; Nieh P; Jani A; Bellamy M; Halkar R; Goodman M; Schuster D
  • Know my radiotracer: Nuclear medicine prototype flash cards for physicians - Part two
    Volume: 55
    05/01/2014 Authors: Savir-Baruch B; Schuster D; Jablonowski E; Barron B
  • Volumetric errors in delineation of liver radioembolization targets
    Volume: 55
    05/01/2014 Authors: Bonta D; Schuster D; Barron B
  • Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma.
    J Vasc Interv Radiol Volume: 25 Page(s): 288 - 295
    02/01/2014 Authors: Eaton BR; Kim HS; Schreibmann E; Schuster DM; Galt JR; Barron B; Kim S; Liu Y; Landry J; Fox T
  • A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
    J Vasc Interv Radiol Volume: 25 Page(s): 277 - 287
    02/01/2014 Authors: Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS
  • Local recurrence patterns in breast cancer patients treated with oncoplastic reduction mammaplasty and radiotherapy.
    Ann Surg Oncol Volume: 21 Page(s): 93 - 99
    01/01/2014 Authors: Eaton BR; Losken A; Okwan-Duodu D; Schuster DM; Switchenko JM; Mister D; Godette K; Torres MA
  • Comparative evaluation of transport mechanisms of trans-1-amino-3-[F]fluorocyclobutanecarboxylic acid and L-[methyl-C]methionine in human glioma cell lines.
    Brain Res Volume: 1535 Page(s): 24 - 37
    10/16/2013 Authors: Ono M; Oka S; Okudaira H; Schuster DM; Goodman MM; Kawai K; Shirakami Y
  • Pilot study of the utility of the synthetic PET amino-acid radiotracer anti-1-amino-3-[(18)F]fluorocyclobutane-1-carboxylic acid for the noninvasive imaging of pulmonary lesions.
    Mol Imaging Biol Volume: 15 Page(s): 633 - 643
    10/01/2013 Authors: Amzat R; Taleghani P; Miller DL; Beitler JJ; Bellamy LM; Nye JA; Yu W; Savir-Baruch B; Osunkoya AO; Chen Z
  • Long-term Outcomes Following Oncoplastic Reduction Mammaplasty: Implications for Radiation Therapy
    Volume: 87 Page(s): S211 - S211
    10/01/2013 Authors: Eaton BR; Losken A; Okwan-Duodu D; Schuster DM; Switchenko JM; Mister D; Godette K; Torres MA
  • Impact of FACBC PET in Imaging and GTV Design of Cerebral Gliomas
    Volume: 87 Page(s): S250 - S250
    10/01/2013 Authors: Marchan EM; Goodman MM; Schuster DM; Vakili J; Olson JJ; Hadjipanayis CG; Brat DJ; Curran WJ; Shu HG; Crocker IR
  • Differences in neural activation for object-directed grasping in chimpanzees and humans.
    J Neurosci Volume: 33 Page(s): 14117 - 14134
    08/28/2013 Authors: Hecht EE; Murphy LE; Gutman DA; Votaw JR; Schuster DM; Preuss TM; Orban GA; Stout D; Parr LA
  • Imaging quality of F-18-FDG PET/CT in the inpatient versus outpatient setting.
    Ann Nucl Med Volume: 27 Page(s): 508 - 514
    07/01/2013 Authors: Yan X; Kang J; Zhou Y; Ehsan R; Halkar R; Applegate KE; Schuster DM
  • Kinetic analyses of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid transport in Xenopus laevis oocytes expressing human ASCT2 and SNAT2.
    Nucl Med Biol Volume: 40 Page(s): 670 - 675
    07/01/2013 Authors: Okudaira H; Nakanishi T; Oka S; Kobayashi M; Tamagami H; Schuster DM; Goodman MM; Shirakami Y; Tamai I; Kawai K
  • PERCIST criteria to predict survival at 3 months following intra-arterial resin-based yttrium-90 (Y-90) radioembolization therapy of unresectable intrahepatic cholangiocarcinoma refractory to standard chemotherapy: A proof of concept study.
    Volume: 31
    05/20/2013 Authors: Camacho JC; Kokabi N; Schuster DM; Kim HS
  • Know my radiotracer: Nuclear medicine prototype flash cards for physicians
    JOURNAL OF NUCLEAR MEDICINE Volume: 54
    05/01/2013 Authors: Savir-Baruch B; Barron B; Jablonowski E; Plaxton N; Moncayo V; Schuster D
  • Database system to allow accurate analysis of large clinical trials
    JOURNAL OF NUCLEAR MEDICINE Volume: 54
    05/01/2013 Authors: Savir-Baruch B; Taleghani PA; Odewole O; Amzat R; Halkar R; Bellamy M; Schuster D
  • Accuracy Evaluation of a 3D Ultrasound-guided Biopsy System.
    Proc SPIE Int Soc Opt Eng Volume: 8671
    03/14/2013 Authors: Wooten WJ; Nye JA; Schuster DM; Nieh PT; Master VA; Votaw JR; Fei B
  • Radiation field design and patterns of locoregional recurrence following definitive radiotherapy for breast cancer.
    Int J Radiat Oncol Biol Phys Volume: 85 Page(s): 309 - 314
    02/01/2013 Authors: Chen SA; Schuster DM; Mister D; Liu T; Godette K; Torres MA
  • Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptake.
    Am J Nucl Med Mol Imaging Volume: 3 Page(s): 85 - 96
    01/01/2013 Authors: Schuster DM; Taleghani PA; Nieh PT; Master VA; Amzat R; Savir-Baruch B; Halkar RK; Fox T; Osunkoya AO; Moreno CS
  • PET-directed, 3D Ultrasound-guided prostate biopsy.
    Diagn Imaging Eur Volume: 29 Page(s): 12 - 15
    01/01/2013 Authors: Fei B; Nieh PT; Schuster DM; Master VA
  • Salvage therapy for locally recurrent prostate cancer after radiation.
    Can J Urol Volume: 19 Page(s): 6534 - 6541
    12/01/2012 Authors: Marcus DM; Canter DJ; Jani AB; Dobbs RW; Schuster DM; Carthon BC; Rossi PJ
  • Image-based Dosimetry for Y-90 Selective Internal Radiation Therapy (SIRT) of Hepatic Metastatic Melanoma: Dose-Volume Analysis Predict FDG-PET Response
    Volume: 84 Page(s): S330 - S330
    11/01/2012 Authors: Eaton BR; Schreibmann E; Schuster DM; Galt J; Barron B; Liu Y; Landry J; Kim HS; Fox T
  • Prognostic value of 18f-fluorodeoxyglucose positron emission tomography-computed tomography in predicting survival in patients with unresectable metastatic melanoma to the liver undergoing yttrium-90 radioembolization.
    J Vasc Interv Radiol Volume: 23 Page(s): 943 - 948
    07/01/2012 Authors: Piduru SM; Schuster DM; Barron BJ; Dhanasekaran R; Lawson DH; Kim HS
  • Hyperspectral imaging and quantitative analysis for prostate cancer detection.
    J Biomed Opt Volume: 17 Page(s): 076005
    07/01/2012 Authors: Akbari H; Halig LV; Schuster DM; Osunkoya A; Master V; Nieh PT; Chen GZ; Fei B
  • Radiohalogenated nonnatural amino acids as PET and SPECT tumor imaging agents.
    Med Res Rev Volume: 32 Page(s): 868 - 905
    07/01/2012 Authors: McConathy J; Yu W; Jarkas N; Seo W; Schuster DM; Goodman MM
  • Heme products post-radiofrequency ablation obscure tumor recurrence on MR but not on PET-CT.
    Nucl Med Mol Imaging Volume: 46 Page(s): 152 - 154
    06/01/2012 Authors: Ehsan SR; Gooden CE; Schuster DM
  • Metastatic Breast Lesion to the Falx Detected with PET-CT.
    Nucl Med Mol Imaging Volume: 46 Page(s): 147 - 149
    06/01/2012 Authors: Harrison C; Schuster DM
  • Increased expression of Ki-67 correlates with synthetic amino acid PET radiotracer uptake in prostate cancer
    Volume: 53
    05/01/2012 Authors: Taleghani P; Amzat R; Osunkoya A; Savir-Baruch B; Nieh P; Master V; Fei B; Fox T; Goodman M; Schuster D
  • Synthetic amino acid PET in primary prostate carcinoma: Correlation of pre-surgical imaging with radical prostatectomy specimens
    JOURNAL OF NUCLEAR MEDICINE Volume: 53
    05/01/2012 Authors: Taleghani P; Amzat R; Osunkoya A; Savir-Baruch B; Nieh P; Master V; Fei B; Fox T; Goodman M; Schuster D
  • Variable synthetic amino acid radiotracer urinary excretion in prostate carcinoma
    JOURNAL OF NUCLEAR MEDICINE Volume: 53
    05/01/2012 Authors: Amzat R; Faraj B; Nye J; Taleghani P; Savir-Baruch B; Crowe R; Yu W; Bellamy L; Goodman M; Schuster D
  • Feasibility of targeted lymph node removal in recurrent prostate carcinoma guided by synthetic amino acid PET: Can we decrease disease burden prior to initiation of systemic therapy?
    JOURNAL OF NUCLEAR MEDICINE Volume: 53
    05/01/2012 Authors: Savir-Baruch B; Amzat R; Taleghani P; Master V; Nieh P; Rossi P; Goodman M; Schuster D
  • Emergent PET-CT findings: Can you make the right call?
    JOURNAL OF NUCLEAR MEDICINE Volume: 53
    05/01/2012 Authors: Brown A; Harrison C; Brandon D; Schuster D
  • Rb-82 positron emission tomography for post radiotherapy brain tumor evaluation: A pilot study
    JOURNAL OF NUCLEAR MEDICINE Volume: 53
    05/01/2012 Authors: Amzat R; Taleghani P; Nye J; Savir-Baruch B; Holder C; Olson J; Crocker I; Voloschin A; Gavrikov V; Schuster D
  • Extraprostatic recurrent prostate carcinoma detection with synthetic amino acid PET/CT surpasses imaging with (111)Indium-capromabpendetide plus diagnostic CT
    JOURNAL OF NUCLEAR MEDICINE Volume: 53
    05/01/2012 Authors: Amzat R; Taleghani P; Savir-Baruch B; Nieh P; Master V; Rossi P; Halkar R; Goodman M; Bowman F; Schuster D
  • In OctreoScan SPECT-MRI fusion for the detection of a pancreatic insulinoma.
    Clin Nucl Med Volume: 37 Page(s): e53 - e56
    03/01/2012 Authors: Moncayo VM; Martin DR; Sarmiento JM; Zbytek B; Fox T; Schuster DM
  • A Molecular Image-directed, 3D Ultrasound-guided Biopsy System for the Prostate.
    Proc SPIE Int Soc Opt Eng Volume: 2012
    01/01/2012 Authors: Fei B; Schuster DM; Master V; Akbari H; Fenster A; Nieh P
  • Transport mechanisms of trans-1-amino-3-fluoro[1-(14)C]cyclobutanecarboxylic acid in prostate cancer cells.
    Nucl Med Biol Volume: 39 Page(s): 109 - 119
    01/01/2012 Authors: Oka S; Okudaira H; Yoshida Y; Schuster DM; Goodman MM; Shirakami Y
  • Pilot evaluation of anti-1-amino-2-[18F] fluorocyclopentane-1-carboxylic acid (anti-2-[18F] FACPC) PET-CT in recurrent prostate carcinoma.
    Mol Imaging Biol Volume: 13 Page(s): 1272 - 1277
    12/01/2011 Authors: Savir-Baruch B; Schuster DM; Jarkas N; Master VA; Nieh PT; Halkar RK; Nye JA; Lewis MM; Crowe RJ; Voll RJ
  • Biodistribution and human dosimetry of enantiomer-1 of the synthetic leucine analog anti-1-amino-2-fluorocyclopentyl-1-carboxylic acid.
    Nucl Med Biol Volume: 38 Page(s): 1035 - 1041
    10/01/2011 Authors: Nye JA; Jarkas N; Schuster DM; Savir-Baruch B; Voll RJ; Camp VM; Goodman MM
  • Incremental benefit of SPECT + CT bone scans over conventional planar and SPECT bone scans in vertebroplasty.
    Indian J Nucl Med Volume: 26 Page(s): 181 - 184
    10/01/2011 Authors: Kumar K; Halkar RK; Bartley SC; Schuster DM
  • Unusual presentations of metastatic prostate carcinoma as detected by anti-3 F-18 FACBC PET/CT.
    Clin Nucl Med Volume: 36 Page(s): 800 - 802
    09/01/2011 Authors: Amzat R; Taleghani P; Savir-Baruch B; Nieh PT; Master VA; Halkar RK; Lewis MM; Faurot M; Bellamy LM; Goodman MM
  • Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT.
    Radiology Volume: 259 Page(s): 852 - 861
    06/01/2011 Authors: Schuster DM; Savir-Baruch B; Nieh PT; Master VA; Halkar RK; Rossi PJ; Lewis MM; Nye JA; Yu W; Bowman FD
  • Pilot study of the utility of anti-1-amino-3-[F-18]fluorocyclobutane-1-carboxylic acid (anti-3-[F-18] FACBC) PET-CT for the non-invasive imaging of lung nodules
    JOURNAL OF NUCLEAR MEDICINE Volume: 52
    05/01/2011 Authors: Amzat R; Alaei P; Savir-Baruch B; Miller D; Beitler J; Bellamy L; Nye J; Yu W; Goodman M; Schuster D
  • Absent coronary artery calcium excludes inducible myocardial ischemia on computed tomography/positron emission tomography.
    Int J Cardiol Volume: 147 Page(s): 424 - 427
    03/17/2011 Authors: Esteves FP; Khan A; Correia LCL; Nye JA; Halkar RK; Schuster DM; Stillman A; Raggi P
  • Histopathologic Correlation of Prostatic Adenocarcinoma on Radical Prostatectomy with Pre-Operative Anti-18F Fluorocyclobutyl-Carboxylic Acid Positron Emission Tomography/Computed Tomography
    Volume: 24 Page(s): 222A - 223A
    02/01/2011 Authors: Schuster D; Fei B; Fox T; Osunkoya AO
  • Histopathologic Correlation of Prostatic Adenocarcinoma on Radical Prostatectomy with Pre-Operative Anti-18F Fluorocyclobutyl-Carboxylic Acid Positron Emission Tomography/Computed Tomography
    Volume: 91 Page(s): 222A - 223A
    02/01/2011 Authors: Schuster D; Fei B; Fox T; Osunkoya AO
  • A PET/CT Directed, 3D Ultrasound-Guided Biopsy System for Prostate Cancer.
    Volume: 6363 Page(s): 100 - 108
    01/01/2011 Authors: Fei B; Master V; Nieh P; Akbari H; Yang X; Fenster A; Schuster D
  • Automatic 3D Segmentation of Ultrasound Images Using Atlas Registration and Statistical Texture Prior.
    Volume: 7964
    01/01/2011 Authors: Yang X; Schuster D; Master V; Nieh P; Fenster A; Fei B
  • Posterior bladder layering of excreted 18F-FDG on PET/CT.
    Nucl Med Commun Volume: 31 Page(s): 859 - 863
    10/01/2010 Authors: Zeng W; Sepulveda JN; Nye J; Votaw JR; Nieh PT; Carew J; Schuster DM
  • MR-based attenuation correction for hybrid PET-MR brain imaging systems using deformable image registration.
    Med Phys Volume: 37 Page(s): 2101 - 2109
    05/01/2010 Authors: Schreibmann E; Nye JA; Schuster DM; Martin DR; Votaw J; Fox T
  • Pilot evaluation of 1-amino-2-[18F]fluorocyclopentane-1-carboxylic acid (anti-2-[18F] FACPC) PET-CT in recurrent prostate carcinoma
    Volume: 51
    05/01/2010 Authors: Savir-Baruch B; Schuster D; Jarkas N; Master V; Nieh P; Halkar R; Nye J; Lewis M; Roberts D; Goodman M
  • Report of a clinical trial of anti-1 amino 3 [18F]fluorocyclobutane-1-carboxylic acid (anti-[18F]FACBC) PET-CT in recurrent prostate carcinoma
    JOURNAL OF NUCLEAR MEDICINE Volume: 51
    05/01/2010 Authors: Schuster D; Savir-Baruch B; Nieh P; Master V; Halkar R; Rossi P; Lewis M; Yu W; Bowman F; Goodman M
  • Prompt-gamma compensation in Rb-82 myocardial perfusion 3D PET/CT.
    J Nucl Cardiol Volume: 17 Page(s): 247 - 253
    04/01/2010 Authors: Esteves FP; Nye JA; Khan A; Folks RD; Halkar RK; Garcia EV; Schuster DM; Lerakis S; Raggi P; Votaw JR
  • Breast angiosarcoma: FDG PET findings.
    Clin Nucl Med Volume: 34 Page(s): 443 - 445
    07/01/2009 Authors: Zeng W; Styblo TM; Li S; Sepulveda JN; Schuster DM
  • Initial report of a clinical trial of anti-1 amino 3 [18F]fluorocyclobutane-1-carboxylic acid (anti-[18F] FACBC) PET-CT in recurrent prostate cancer
    JOURNAL OF NUCLEAR MEDICINE Volume: 50
    05/01/2009 Authors: Schuster D; Savir-Baruch B; Nieh P; Votaw J; Nye J; Master V; Halkar R; Bowman F; Goodman M
  • Case study of anti-1-amino-3-F-18 fluorocyclobutane-1-carboxylic acid (anti-[F-18] FACBC) to guide prostate cancer radiotherapy target design.
    Clin Nucl Med Volume: 34 Page(s): 279 - 284
    05/01/2009 Authors: Jani AB; Fox TH; Whitaker D; Schuster DM
  • Initial experience with the radiotracer anti-1-amino-3-[18F]Fluorocyclobutane-1-carboxylic acid (anti-[ 18F]FACBC) with PET in renal carcinoma.
    Mol Imaging Biol Volume: 11 Page(s): 434 - 438
    01/01/2009 Authors: Schuster DM; Nye JA; Nieh PT; Votaw JR; Halkar RK; Issa MM; Yu W; Sepulveda J; Zeng W; Young A
  • Investigation of emission-transmission misalignment artifacts on rubidium-82 cardiac PET with adenosine pharmacologic stress.
    Mol Imaging Biol Volume: 10 Page(s): 201 - 208
    01/01/2008 Authors: Schuster DM; Halkar RK; Esteves FP; Garcia EV; Cooke CD; Syed MA; Bowman FD; Votaw JR
  • Sarcoid-like reaction in the spleen following chemotherapy for non-Hodgkin's lymphoma.
    Clin Nucl Med Volume: 32 Page(s): 569 - 571
    07/01/2007 Authors: Reilly TB; Schuster DM; Starsiak MD; Kost CB; Halkar RK
  • Biodistribution and radiation dosimetry of the synthetic nonmetabolized amino acid analogue anti-18F-FACBC in humans.
    J Nucl Med Volume: 48 Page(s): 1017 - 1020
    06/01/2007 Authors: Nye JA; Schuster DM; Yu W; Camp VM; Goodman MM; Votaw JR
  • Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma.
    J Nucl Med Volume: 48 Page(s): 56 - 63
    01/01/2007 Authors: Schuster DM; Votaw JR; Nieh PT; Yu W; Nye JA; Master V; Bowman FD; Issa MM; Goodman MM
  • Radionuclide imaging for hyperparathyroidism (HPT): which is the best technetium-99m sestamibi modality?
    Surgery Volume: 140 Page(s): 856 - 863
    12/01/2006 Authors: Sharma J; Mazzaglia P; Milas M; Berber E; Schuster DM; Halkar R; Siperstein A; Weber CJ
  • Choroidal melanoma with hematogenous spread to the liver: F-18 FDG PET/CT findings.
    Clin Nucl Med Volume: 31 Page(s): 347 - 348
    06/01/2006 Authors: Bawa M; Sidhu G; Galt JR; Schuster DM; Halkar RK
  • PET-CT vs contrast-enhanced CT: what is the role for each after chemoradiation for advanced oropharyngeal cancer?
    Head Neck Volume: 28 Page(s): 487 - 495
    06/01/2006 Authors: Chen AY; Vilaseca I; Hudgins PA; Schuster D; Halkar R
  • Gastrointestinal tract malignancies and positron emission tomography: an overview.
    Semin Nucl Med Volume: 36 Page(s): 169 - 181
    04/01/2006 Authors: Esteves FP; Schuster DM; Halkar RK
  • Xanthogranulomatous pyelonephritis characterized on PET/CT.
    Clin Nucl Med Volume: 30 Page(s): 728 - 729
    11/01/2005 Authors: Swingle CA; Baumgarten DA; Schuster DM
  • F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer.
    Head Neck Volume: 27 Page(s): 494 - 502
    06/01/2005 Authors: Koshy M; Paulino AC; Howell R; Schuster D; Halkar R; Davis LW
  • Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer.
    Int J Radiat Oncol Biol Phys Volume: 61 Page(s): 1385 - 1392
    04/01/2005 Authors: Paulino AC; Koshy M; Howell R; Schuster D; Davis LW
  • Central line injection artifact simulating paratracheal adenopathy on FDG PET imaging.
    Clin Nucl Med Volume: 29 Page(s): 735 - 737
    11/01/2004 Authors: Ravizzini G; Nguyen M; Schuster DM; Halkar RK
  • Molecular imaging in breast cancer.
    Radiol Clin North Am Volume: 42 Page(s): 885 - vii
    09/01/2004 Authors: Schuster DM; Halkar RK
  • Influence of F-18FDG PET-CT fusion on radiotherapy treatment planning for head and neck cancer.
    Volume: 22 Page(s): 496S - 496S
    07/15/2004 Authors: Koshy M; Paulino AC; Howell R; Schuster D; Halkar R; Davis L
  • Volumetric analysis of the PET-CT defined target in intensity modulated radiotherapy for head and neck cancer
    Volume: 60 Page(s): S492 - S492
    01/01/2004 Authors: Koshy M; Paulino AC; Howell R; Schuster D; Halkar R; Davis L
  • False positive uptake in granulomatous disease with FDG PET-CT
    Volume: 182 Page(s): 49 - 49
    01/01/2004 Authors: Hartman MS; Schuster DM; Tigges S; Gal AA; Gruden JF
  • CT with histopathologic correlation of FDG uptake in a patient with pulmonary granuloma and pleural plaque caused by remote talc pleurodesis.
    AJR Am J Roentgenol Volume: 182 Page(s): 92 - 94
    01/01/2004 Authors: Nguyen M; Varma V; Perez R; Schuster DM
  • Validation of human estimated radiation dosimetry from animal data for the synthetic PET amino acid radiotracer 1-amino-3-[F-18]fluorocyclobutane-1-carboxylic acid (F-18-FACBC).
    Volume: 44 Page(s): 322P - 323P
    05/01/2003 Authors: Schuster DM; Votaw JR; Halkar RK; McConathy J; Crowe RJ; Olson J; Goodman MM
  • Uptake of the synthetic PET amino acid radiotracer 1-amino-3-[F-18]fluorocyclobutane-1-carboxylic acid (F-18-FACBC) within primary and metastatic brain cancer compared with 18F-fluorodeoxyglucose (F-18-FDG).
    Volume: 44 Page(s): 167P - 167P
    05/01/2003 Authors: Schuster DM; Votaw JR; Halkar RK; McConathy J; Crowe RJ; Olson J; Goodman MM
  • Involving users in the implementation of an imaging order entry system.
    J Am Med Inform Assoc Volume: 10 Page(s): 315 - 321
    01/01/2003 Authors: Schuster DM; Hall SE; Couse CB; Swayngim DS; Kohatsu KY
  • Gallium and other agents in diseases of the lung.
    Semin Nucl Med Volume: 32 Page(s): 193 - 211
    07/01/2002 Authors: Schuster DM; Alazraki N
  • Jejunal diverticular hemorrhage localized by red blood cell scintigraphy.
    Clin Nucl Med Volume: 26 Page(s): 936 - 937
    11/01/2001 Authors: Schuster DM; Chapman WE; Ahl ET; Ahearne P
  • Malignant supraclavicular lymph node visualization during Tc-99m HDP bone imaging.
    Clin Nucl Med Volume: 25 Page(s): 376 - 377
    05/01/2000 Authors: Schuster DM
  • Indeterminate adrenal masses.
    J Nucl Med Volume: 41 Page(s): 963
    05/01/2000 Authors: Schuster DM
  • Nonuniform attenuation: Not just in myocardial perfusion imaging.
    Volume: 39 Page(s): 276P - 276P
    05/01/1998 Authors: Wilson DA; Halkar RK; Galt JR; Schuster D; Scheidt KA; Fajman WJ
  • Esophageal scarring causing false-positive uptake on I-131 whole-body imaging.
    Clin Nucl Med Volume: 23 Page(s): 334
    05/01/1998 Authors: Schuster DM; Alazraki N
  • The use of the diagnostic radionuclide ascites scan to facilitate treatment decisions for hepatic hydrothorax.
    Clin Nucl Med Volume: 23 Page(s): 16 - 18
    01/01/1998 Authors: Schuster DM; Mukundan S; Small W; Fajman WA
  • One possible future.
    J Altern Complement Med Volume: 4 Page(s): 255 - 256
    01/01/1998 Authors: Schuster DM
  • Artifactual perfusion defect from a hypertrophic first costosternal articulation.
    Clin Nucl Med Volume: 22 Page(s): 642
    09/01/1997 Authors: Schuster DM; Scheidt K
  • The malady of incomplete, inadequate, and inaccurate radiology requisition histories: a computerized treatment.
    AJR Am J Roentgenol Volume: 167 Page(s): 855 - 859
    10/01/1996 Authors: Schuster DM; Gale ME
  • A little secret sinning
    RADIOGRAPHICS Volume: 16 Page(s): 786 - 786
    07/01/1996 Authors: Schuster DM; Lampka JV
  • The integrative hospital explored via acupuncture.
    J Altern Complement Med Volume: 2 Page(s): 503 - 514
    01/01/1996 Authors: Schuster DM
  • MAGNETIC-RESONANCE CHOLANGIOGRAPHY - A USEFUL DERIVATIVE OF ROUTINE ABDOMINAL MRI
    GASTROENTEROLOGY Volume: 108 Page(s): A432 - A432
    04/01/1995 Authors: PEDROSA MC; SCHUSTER DM; ROBBINS AH
  • Hospital 2000: the interface of radiology within a combined "complementary-allopathic" medicine framework.
    J Altern Complement Med Volume: 1 Page(s): 333 - 337
    01/01/1995 Authors: Schuster DM
  • Magnetic resonance cholangiography.
    Abdom Imaging Volume: 20 Page(s): 353 - 356
    01/01/1995 Authors: Schuster DM; Pedrosa MC; Robbins AH
  • Duodenal perforation by a biliary endoprosthesis: evaluation by hepatobiliary scintigraphy.
    J Clin Gastroenterol Volume: 15 Page(s): 177 - 179
    09/01/1992 Authors: Schuster D; Achong DM; Knox TA; Fawaz KA
  • Legionellosis in cardiac transplant recipients: results of a nationwide survey.
    J Infect Dis Volume: 158 Page(s): 651 - 653
    09/01/1988 Authors: Redd SC; Schuster DM; Quan J; Plikaytis BD; Spika JS; Cohen ML
  • False-positive DNA probe test for Legionella species associated with a cluster of respiratory illnesses.
    J Clin Microbiol Volume: 26 Page(s): 1442 - 1444
    08/01/1988 Authors: Laussucq S; Schuster D; Alexander WJ; Thacker WL; Wilkinson HW; Spika JS
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2024 Emory University
  • Privacy Policy
  • Emergency Information